Transfusion-transmitted infections: Existing and emerging pathogens

Journal of Postgraduate Medicine

Volumn 51, Issue 2, 2005, Pages 146-151

  Kaur, P ^a   Basu, S ^a  

^a GOVERNMENT MEDICAL COLLEGE AND HOSPITAL   (India)

Author keywords

Emerging pathogens; Transfusion transmitted infections

Indexed keywords

BLOOD CLOTTING FACTOR 8 INHIBITOR;

ANTIGEN DETECTION; BABESIOSIS; BACTERIAL INFECTION; BACTERIUM CONTAMINATION; BLOOD ANALYSIS; BLOOD COMPONENT; BLOOD DONOR; BLOOD STORAGE; BLOOD TRANSFUSION; CYTOMEGALOVIRUS; DATA ANALYSIS; EPSTEIN BARR VIRUS; HEMOPHILIA; HEPATITIS VIRUS; HUMAN; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T CELL LEUKEMIA VIRUS 1; INFECTION; INFECTION RISK; LEISHMANIASIS; MEDLINE; MICROFILARIASIS; MICROORGANISM DETECTION; PARASITOSIS; PARVOVIRUS; PRION; PRION DISEASE; REVIEW; RISK REDUCTION; SENSITIVITY ANALYSIS; SYPHILIS; TRYPANOSOMA; VIRUS GENOME; VIRUS INFECTION; WEST NILE FLAVIVIRUS;

ANIMALS; BACTERIAL INFECTIONS; BLOOD TRANSFUSION; HUMANS; PROTOZOAN INFECTIONS; VIRUS DISEASES;

EID: 22144442781     PISSN: 00223859     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (63)

1. Dodd RY. Adverse consequences of blood transfusion: Quantitative risk estimates. In Nance ST, editor. Blood Supply: Risks, Perceptions and Prospects for the Future. Bethesda, MD: Am Assoc Blood Banks; 1994; p. 1-24.
2. Giacoia GP, Kasprisin DO. Transfusion acquired hepatitis A. South Med J 1989;82:1357-60.
3. Mannucci PM, Gdovin S, Gringeri A, Colombo M, Mele A, Schinaia N, et al. Transmission of hepatitis A to patients with hemophilia by factor VIII concentrates treated with organic solvent and detergent to inactivate viruses. Ann Intern Med 1994;120:1-7.
4. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. N Engl J Med 1996;334:1685-90.
5. Sharma RR, Cheema R, Vajpayee M, Rao U, Kumar S, Marwaha N, et al. Prevalence of markers of transfusion transmissible diseases in voluntary and replacement blood donors. Natl Med J India 2004;17:19-21.
6. Garg S, Mathur DR, Garg DK. Comparison of seropositivity of HIV, HBV, HCV and syphilis in replacement and voluntary blood donors in western India. Indian J Pathol Microbiol 2001;44:409-12.
7. Choudhury N, Ramesh V, Saraswat S, Naik S. Effectiveness of mandatory transmissible diseases screening in Indian blood donors. Indian J Med Res 1995;101:229-32.
8. Chandrasekaran S, Palaniappan N, Krishnan V, Mohan G, Chandrasekaran N. Relative prevalence of hepatitis B viral markers and hepatitis C virus antibodies (anti HCV) in Madurai, south India. Indian J Med Sci 2000;54:270-3.
9. Srikrishna A, Sitalakshmi S, Damodar P. How safe are our safe donors? Indian J Pathol Microbiol 1999;42:411-6.
10. Freidman DF. Hepatitis. In Hillyer CD, Hillyer KL, Strobl FJ, Jefferies LC, Silberstein LE, editors. Handbook of Transfusion Medicine. San Diego: Academic Press; 2001, p. 275-83.
11. Gupta N, Kumar V, Kaur A. Seroprevalence of HIV, HBV, HCV and syphilis in voluntary blood donors. Indian J Med Sci 2004;58:255-7.
12. Schreiber GB, Busch MP, Kleinman SH. Authors reply to letter to the editor. N Engl J Med 1996;335:1610.
13. Wilkinson SL, Lipton SK. NAT implementation. AABB Association Bulletin. Bethesda, MD: Am Assoc Blood Banks; 1999, p. 99-103.
14. Busch MP, Glynn SA, Stramer SL, Strong DM, Caglioti S, Wright DJ, et al. A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors. Transfusion 2005;45:254-64.
15. Sayers M. Cytomegalovirus and other herpes viruses. In : Petz LD, Swisher SN, Kleinman S, Spence RK, Strauss RG, editors. Clinical practice of transfusion medicine 3rd Edn. New York: Churchill Livingstone; 1996, p. 875-89.
16. Brecher ME, editor. AABB Technical Manual 14th Edn. Bethesda, MD: Am Assoc Blood Banks; 2002.
17. Kleinman S. Donor selection and screening procedures. In : Nance ST, editor. Blood safety: Current challenges. Bethesda, MD: Am Assoc Blood Banks; 1992, p. 169-200.
18. Mayo DJ, Rose AM, Matchett SE, Hoppe PA, Solomon JM, McCurdy KK. Screening potential blood donors at risk for human immunodeficiency virus. Transfusion 1991;31:466-74.
19. Johnson ES, Doll LS, Satten GA, Lenes B, Shafer AW, Kamel H, et al. Direct oral questions to blood donors: The impact on screening for human immunodeficiency virus. Transfusion 1994;34:769-74.
20. Mayer A, Busch MP. Transfusion-transmitted HIV infection. In : Anderson KL, Ness P, editors. The scientific basis of transfusion medicine: Implications for clinical practice. Philadelphia: WB Saunders; 1994, p. 659-68.
21. Fauci AS. Multifactorial nature of human immunodeficiency virus disease: Implications for therapy. Science 1993;262:1011-8.
22. Korber BT, MacInnes K, Smith RF, Myers G. Mutational trends in V3 loop protein sequences observed in different genetic lineages of human immunodeficiency virus type 1. J Virol 1994;68:6730-44.
23. Nkengasong JN, Janssens W, Heyndrickx L, Fransen K, Ndumbe PM, Motte J, et al. Genotypic subtypes of HIV-1 in Cameroon. AIDS 1994;8:1405-12.
24. Gao F, Yue L, Robertson DL, Hill SC, Hui H, Biggar RJ, et al. Genetic diversity of human immunodeficiency virus type 2: Evidence for distinct sequences subtypes with differences in viral biology. J Virol 1994;68:7433-47.
25. Kakkar N, Kaur R, Dhanoa J. Voluntary donors - need for a second look. Indian J Pathol Microbiol 2004;47:381-3.
26. Singh B, Kataria SP, Gupta R. Infectious markers in blood donors of East Delhi - prevalence and trends. Indian J Pathol Microbiol 2004;47:477-9.
27. Nanu A, Sharma SP, Chatterjee K, Jyoti P. Markers for transfusion transmissible infections in north Indian voluntary and replacement blood donors: Prevalence and trends. 1989-1996. Vox Sang 1997;73:70-3.
28. Hjelle B. Transfusion-transmitted HTLV-I and HTLV-II. In : Rossi EC, Simon TL, Moss GL, Gould SA, editors. Principles of transfusion medicine. 2nd Edn. Baltimore, MD: Williams and Wilkins; 1995, p. 709-16.
29. Guidelines for counseling persons infected with human T-lymphotropic virus type I (HTLV-I) and type II (HTLV-II). Centers for Disease Control and Prevention and the U.S.P.H.S. Working Group. Ann Intern Med 1993;118:448-54.
30. Okochi K, Sato H, Hinuma Y. A retrospective study on transmission of adult T cell leukemia virus by blood transfusion: Seroconversion in recipients. Vox Sang 1984;46:245-53.
31. Lairmore MD, Jason JM, Hartley TM, Khabbaz RF, De B, Evatt BL. Absence of human T-Cell lymphotropic virus type I coinfection in human immunodeficiency virus - infected hemophilic men. Blood 1989;74:2596-9.
32. Kleinman S, Swanson P, Allain JP, Lee H. Transfusion transmission of human T-lymphotropic virus types I and II: Serologic and polymerase chain reaction results in recipients identified through look-back investigations. Transfusion 1993;33:14-8.
33. Food and Drug Administration. Guidance for industry: Donor screening for antibodies to HTLV-II (August 15, 1997) Rockville, MD: CBER office of Communication, Training and Manufacturer's Assistance;1997.
34. Gunter K, Luban N. Transfusion-transmitted cytomegalovirus and Epstein Barr virus diseases. In : Rossi EC, Simon TL, Moss GL, Gould SA, editors. Principles of transfusion medicine. 2nd Edn. Baltimore: Williams and Wilkins; 1995, p. 717-32.
35. Raynor BD. Cytomegalovirus infection in pregnancy. Semin Perinatol 1993;17:394-402.
36. Bolovan-Fritts CA, Mocarski ES, Wiedeman JA. Peripheral blood CD14(+) cells from healthy subjects carry a circular conformation of latent cytomegalovirus genome. Blood 1999;93:394-8.
37. Miller WJ, McCullough J, Balfour HH Jr, Haake RJ, Ramsay NK, Goldman A, et al. Prevention of cytomegalovirus infection following bone marrow transplantation: A randomized trial of blood product screening. Bone Marrow Transplant 1991;7:227-34.
38. Larsson S, Soderberg-Naucler C, Wang FZ, Moller E. Cytomegalovirus DNA can be detected in peripheral blood mononuclear cells from all seropositive and most seronegative healthy blood donors over time. Transfusion 1998;38:271-8.
39. Campadelli-Fiume G, Mirandola P, Menotti L. Human herpes virus 6: An emerging pathogen. Emerg Infect Dis 1999;5:353-66.
40. Chatlynne LG, Lapps W, Handy M, Huang YQ, Masood R, Hamilton AS, et al. Detection and titration of human herpes virus 8 specific antibodies in sera from blood donors, acquired immunodeficiency syndrome patients, and Kaposi's sarcoma patients using a whole virus enzyme linked immunosorbent assay. Blood 1998;92:53-8.
41. Operskalski EA, Busch MP, Mosley JW, Kedes DH. Blood donations and viruses. (letter) Lancet 1997;349:1327.
42. Luban NL. Human parvoviruses: Implications for transfusion medicine. Transfusion 1994;34:821-7.
43. Prowse C, Ludlam CA, Yap PL. Human parvovirus B19 and blood products. Vox Sang 1997;72:1-10.
44. Arnold DM, Neame PB, Meyer RM, Soamboonsrup P, Luinstra KE, O'Hoski P, et al. Autologous peripheral blood progenitor cells are a potential source of parvovirus B19 infection. Transfusion 2005;45:394-8.
45. Biggerstaff BJ, Peterson LR. Estimated risk of transmission of West Nile Virus through blood transfusion in the US, 2002; Transfusion 2003;43:1007-17.
46. Manuelidis L. The dimensions of Creutzfeldt-Jacob disease. Transfusion 1994;34:915-28.
47. Morrow JF, Braine HG, Kickler TS, Ness PM, Dick JD, Fuller AK. Septic reactions to platelet transfusions. A persistent problem. JAMA 1991;266:555-8.
48. Cooper L, Brecher M. Bacterial contamination. In : Linden JV, Bianco C, editors. Blood safety and surveillance. New York: Marcel Dekker; 2001, p. 221-50.
49. Brecher ME, Means N, Jere CS, Heath D, Rothenberg S, Stutzman LC. Evaluation of an automated culture system for detecting bacterial contamination of platelets. An analysis with 15 contaminating organisms. Transfusion 2001;41:477-82.
50. van der Sluis JJ, ten Kate FJ, Vuzevski VD, Kothe FC, Aelbers GM, van Eijk RV. Transfusion syphilis, survival of Treponema pallidum in stored donor blood. II. Dose dependence of experimentally determined survival times. Vox Sang 1985;49:390-9.
51. Walker RH, editor. AABB Technical Manual, 11th Edn. Bethesda MD: Am Assoc Blood Banks; 1993.
52. Ness PM. Bacterial and protozoal infections transmitted by transfusion. In : Rossi EC, Simon TL, Moss GS, editors. Principles of Transfusion Medicine. 1st Edn. Baltimore MD: Williams and Wilkins; 1991, p. 611-8.
53. Guerrero IC, Weniger BG, Schultz MG. Transfusion malaria in the United States, 1972-1981. Ann Intern Med 1983;99:221-6.
54. Bruce-Chwatt LJ. Transfusion malaria. Bull World Health Organ 1974;50:337-46.
55. Choudhury N, Jolly JG, Mahajan RC, Ganguly NK, Dubey ML, Agnihotri SK. Malaria screening to prevent transmission by transfusion: An evaluation of techniques. Med Lab Sci 1991;48:206-11.
56. Grabowski EF, Giardina PJ, Goldberg D, Masur H, Read SE, Hirsch RL, et al. Babesiosis transmitted by a transfusion of frozen thawed blood. Ann Intern Med 1982;96:466-7.
57. Jacoby GA, Hunt JV, Kosinski KS, Demirjian ZN, Huggins C, et al. Treatment of transfusion-transmitted babesiosis by exchange transfusion. N Engl J Med 1980;33:1098-100.
58. Shulman I. Transmission of parasitic infections by blood transfusion. In : Rossi EC, Simon TL, Moss GL, Gould SA, editors. Principles of transfusion medicine 2nd Edn. Baltimore MD: Williams and Wilkins; 1995, p. 733-8.
59. Wendel S. Current concepts on transmission of bacteria and parasites by blood components. Vox Sang 1994;67:161-74.
60. Mazzotti L, Palomo E. A note on the survival of the microfilariae of Mansonella ozzardi. Bull World Health Organ 1957;16:696-9.
61. Ben-Hur E, Moor AC, Margolis-Nunno H, Gottlieb P, Zuk MM, Lustigman S, et al. The photodecontamination of cellular blood components: mechanisms and use of photosensitization in transfusion medicine. Transfus Med Rev 1996;10:15-22.
62. Zhang QX, Edson C, Budowsky E, Purmal A. InactineTM- a method for viral inactivation in red blood cell concentrates (abstract).Transfusion 1998;38:75.
63. Lusher JM, Arkin S, Abildgaard CF, Schwartz RS. Recombinant factor VIII for the treatment of previously untreated patients with hemophilia A. Safety, efficacy and development of inhibitors.Kogenate previously untreated patient study group. N Engl J Med 1993;328:453-9.